• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔假性黏液瘤复发的不常见部位:细胞减灭术和腹腔热灌注化疗后——一例小肠腔内疾病表现的病例报告。

Unusual site of pseudomyxoma peritonei recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report of intraluminal disease manifestation in the small bowel.

机构信息

Division of Imaging and Cancer, University Medical Centre Utrecht, Room G.04.2.28, PO Box 85500, 3508 GA, Utrecht, The Netherlands.

Department of Surgery, St. Antonius Hospital, 3435 CM, Nieuwegein, The Netherlands.

出版信息

World J Surg Oncol. 2022 May 10;20(1):147. doi: 10.1186/s12957-022-02613-2.

DOI:10.1186/s12957-022-02613-2
PMID:35538541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9088063/
Abstract

BACKGROUND

Pseudomyxoma peritonei (PMP) is an uncommon clinical condition characterized by the presence of mucinous ascites, mainly induced by perforated appendiceal mucinous neoplasms (AMN). The peritoneal surface of the small bowel is usually spared from disease manifestation due to peristaltic movements. Mucinous tumours can disseminate as PMP on the entire peritoneum, but are rarely intraluminal. For the first time in literature, we report a case of intraluminal PMP involving the ileum.

CASE PRESENTATION

A 75-year-old male was treated for perforated AMN and disseminated PMP with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. During follow-up, the patient developed intraperitoneal recurrence together with intraluminal depositions in the ileum, both disease manifestations with identical KRAS and SMAD4 mutations. Hereafter, the patient was treated with palliative care.

CONCLUSION

This case illustrates the variation in the biological and clinical behaviour of this rare disease. Clinicians should be aware of unusual tumour distribution patterns of PMP, including the presence of mucinous tumour within the small bowel.

摘要

背景

假性黏液瘤腹膜病(PMP)是一种罕见的临床病症,其特征为存在黏液性腹水,主要由穿孔性阑尾黏液性肿瘤(AMN)引起。由于蠕动运动,小肠的腹膜表面通常不会出现疾病表现。黏液性肿瘤可能以 PMP 的形式在整个腹膜上扩散,但很少在肠腔内。我们首次在文献中报告了一例累及回肠的肠腔内 PMP。

病例介绍

一名 75 岁男性因穿孔性 AMN 接受了细胞减灭术和腹腔热灌注化疗治疗,随后发生播散性 PMP。在随访过程中,患者出现了腹腔内复发和回肠内的肠腔内沉积,这两种疾病表现均具有相同的 KRAS 和 SMAD4 突变。此后,患者接受姑息治疗。

结论

本病例说明了这种罕见疾病的生物学和临床行为的变化。临床医生应注意 PMP 的不常见肿瘤分布模式,包括小肠内存在黏液性肿瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e55/9088063/c835033f2ae6/12957_2022_2613_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e55/9088063/1ae8988b9e0e/12957_2022_2613_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e55/9088063/05711ceabecd/12957_2022_2613_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e55/9088063/c39ad84e4a08/12957_2022_2613_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e55/9088063/c835033f2ae6/12957_2022_2613_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e55/9088063/1ae8988b9e0e/12957_2022_2613_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e55/9088063/05711ceabecd/12957_2022_2613_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e55/9088063/c39ad84e4a08/12957_2022_2613_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e55/9088063/c835033f2ae6/12957_2022_2613_Fig4_HTML.jpg

相似文献

1
Unusual site of pseudomyxoma peritonei recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report of intraluminal disease manifestation in the small bowel.腹腔假性黏液瘤复发的不常见部位:细胞减灭术和腹腔热灌注化疗后——一例小肠腔内疾病表现的病例报告。
World J Surg Oncol. 2022 May 10;20(1):147. doi: 10.1186/s12957-022-02613-2.
2
Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.512例阑尾黏液性肿瘤穿孔所致腹膜假黏液瘤患者在肿瘤完全切除及腹腔热灌注化疗后的复发情况及预后
Eur J Surg Oncol. 2015 Mar;41(3):396-9. doi: 10.1016/j.ejso.2014.08.476. Epub 2014 Sep 2.
3
A case of pseudomyxoma peritonei arising from a perforated intraductal papillary mucinous neoplasm that underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.一例源于穿孔性胰管内乳头状黏液性肿瘤的假性黏液瘤腹膜病,行细胞减灭术和腹腔热灌注化疗。
Clin J Gastroenterol. 2024 Feb;17(1):188-197. doi: 10.1007/s12328-023-01890-y. Epub 2023 Nov 18.
4
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study.阑尾来源的假性黏液瘤行细胞减灭术(CRS)和腹腔内热灌注化疗(HIPEC):单中心研究结果。
Updates Surg. 2020 Dec;72(4):1207-1212. doi: 10.1007/s13304-020-00788-5. Epub 2020 May 14.
5
Analysis of causes and prognostic impact of tube occlusion during hyperthermic intraperitoneal chemotherapy for appendiceal pseudomyxoma peritonei.分析阑尾黏液性囊腺癌腹膜假性黏液瘤行腹腔热灌注化疗时发生管腔堵塞的原因及其对预后的影响。
World J Surg Oncol. 2024 May 21;22(1):134. doi: 10.1186/s12957-024-03412-7.
6
Rare occurrence of pseudomyxoma peritonei (PMP) syndrome arising from a malignant transformed ovarian primary mature cystic teratoma treated by cytoreductive surgery and HIPEC: a case report.罕见的由恶性转化的卵巢原发性成熟囊性畸胎瘤引起的腹膜假黏液瘤(PMP)综合征经细胞减灭术和 HIPEC 治疗:一例报告。
World J Surg Oncol. 2022 Mar 11;20(1):78. doi: 10.1186/s12957-022-02548-8.
7
Health related quality of life is excellent and sustained at two decades after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in survivors of pseudomyxoma peritonei of appendiceal origin.阑尾来源的假性黏液瘤腹膜转移患者行细胞减灭术和腹腔热灌注化疗后 20 年,其健康相关生活质量仍然极佳且保持稳定。
Eur J Surg Oncol. 2023 Nov;49(11):107045. doi: 10.1016/j.ejso.2023.107045. Epub 2023 Aug 29.
8
Pleuropulmonary Recurrence Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Appendiceal Pseudomyxoma Peritonei.阑尾黏液性肿瘤腹膜假性黏液瘤行细胞减灭术和腹腔内热灌注化疗后肺胸膜复发。
Ann Surg Oncol. 2019 May;26(5):1429-1436. doi: 10.1245/s10434-018-07091-z. Epub 2019 Jan 8.
9
Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.腹腔热灌注化疗后减瘤手术后假性黏液瘤腹膜复发。
BJS Open. 2018 Sep 27;3(2):195-202. doi: 10.1002/bjs5.97. eCollection 2019 Apr.
10
Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center.阑尾来源的假性黏液瘤行细胞减灭术加腹腔内热灌注化疗后的围手术期安全性:单中心 254 例患者的经验。
Eur J Surg Oncol. 2020 Apr;46(4 Pt A):600-606. doi: 10.1016/j.ejso.2020.01.017. Epub 2020 Jan 15.

引用本文的文献

1
Pseudomyxoma Peritonei With Suspected Gastroesophageal Junction Mass: A Rare and Atypical Presentation.伴有疑似胃食管交界区肿物的腹膜假黏液瘤:一种罕见的非典型表现。
Cureus. 2025 Aug 1;17(8):e89220. doi: 10.7759/cureus.89220. eCollection 2025 Aug.

本文引用的文献

1
Managing Recurrent Pseudomyxoma Peritonei in 430 Patients After Complete Cytoreduction and HIPEC: A Dilemma for Patients and Surgeons.430 例完全细胞减灭术和 HIPEC 后复发性假性黏液瘤的管理:患者和外科医生的困境。
Ann Surg Oncol. 2021 Nov;28(12):7809-7820. doi: 10.1245/s10434-021-10093-z. Epub 2021 May 26.
2
Pseudomyxoma Peritonei Originating from Transverse Colon Mucinous Adenocarcinoma: A Case Report and Literature Review.源于横结肠黏液腺癌的腹膜假黏液瘤:一例报告及文献复习
Gastroenterol Res Pract. 2020 Jul 3;2020:5826214. doi: 10.1155/2020/5826214. eCollection 2020.
3
Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment.
阑尾肿瘤和腹膜假黏液瘤:文献综述及 PSOGI/EURACAN 诊断和治疗临床实践指南。
Eur J Surg Oncol. 2021 Jan;47(1):11-35. doi: 10.1016/j.ejso.2020.02.012. Epub 2020 Feb 28.
4
Molecular and Genetic Markers in Appendiceal Mucinous Tumors: A Systematic Review.阑尾黏液性肿瘤的分子和遗传标志物:系统评价。
Ann Surg Oncol. 2020 Jan;27(1):85-97. doi: 10.1245/s10434-019-07879-7. Epub 2019 Oct 3.
5
Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei.广泛假性黏液瘤腹膜后行完全细胞减灭术和 HIPEC 的生存情况。
Surg Oncol. 2019 Jun;29:78-83. doi: 10.1016/j.suronc.2019.03.004. Epub 2019 Apr 3.
6
Factors influencing long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms.影响阑尾肿瘤来源的假性黏液瘤经细胞减灭术和腹腔热灌注化疗后长期生存的因素。
BJS Open. 2019 Feb 19;3(3):376-386. doi: 10.1002/bjs5.50134. eCollection 2019 Jun.
7
Pseudomyxoma peritonei induced by low-grade appendiceal mucinous neoplasm accompanied by rectal cancer: a case report and literature review.低度阑尾黏液性肿瘤伴直肠癌所致腹膜假黏液瘤:1例报告及文献复习
BMC Surg. 2019 Apr 25;19(1):42. doi: 10.1186/s12893-019-0508-6.
8
Pathophysiology and classification of pseudomyxoma peritonei.腹膜假黏液瘤的病理生理学与分类
Pleura Peritoneum. 2016 Mar 1;1(1):3-13. doi: 10.1515/pp-2016-0008. Epub 2016 Apr 12.
9
Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei.综述:黏液性阑尾肿瘤和腹膜假黏液瘤的病理学及其临床相关性。
Clin Colorectal Cancer. 2019 Mar;18(1):1-7. doi: 10.1016/j.clcc.2018.11.007. Epub 2018 Dec 6.
10
/./.
J Clin Pathol. 2018 Aug;71(8):661-664. doi: 10.1136/jclinpath-2018-205095. Epub 2018 May 2.